Pleurotus eryngii Mushrooms Fermented with Human Fecal Microbiota Protect Intestinal Barrier Integrity: Immune Modulation and Signalling Pathways Counter Deoxycholic Acid-Induced Disruption in Healthy Colonic TissueVisa övriga samt affilieringar
2025 (Engelska)Ingår i: Nutrients, E-ISSN 2072-6643, Vol. 17, nr 4, artikel-id 694
Artikel i tidskrift (Refereegranskat) Published
Abstract [en]
Background: This study explores the potential of the Pleurotus eryngii mushroom fermentation supernatant (FS-PEWS) as an intervention for mitigating sodium deoxycholate (SDC)-induced intestinal barrier dysfunction and inflammation.
Methods: FS-PEWS was assessed for its protective effects against SDC-induced barrier dysfunction and inflammation using an in vitro Caco-2 cell model and ex vivo colonic biopsies from healthy adult donors, where barrier integrity, permeability, immunomodulation and receptor-mediated pathways were evaluated.
Results: In Caco-2 cells, SDC exposure downregulated ZO-1, occludin, and claudin-1 expression, with FS-PEWS restoring ZO-1 and claudin-1 levels while maintaining cell viability. In colonic biopsies from healthy adults, FS-PEWS maintained tissue integrity and selectively mitigated transcellular permeability without affecting paracellular permeability when combined with the stressor. Additionally, FS-PEWS exhibited potent anti-inflammatory effects, reducing pro-inflammatory cytokines, e.g., TNF-α, IL-6, and IL-1β and modulating receptor-mediated pathways, i.e., TLR-4, dectin-1.
Conclusions: These results demonstrate the potential of FS-PEWS to sustain intestinal barrier function and modulate immune responses under stress, highlighting its therapeutic potential for managing gut barrier dysfunction and inflammation associated with microbial metabolite-induced disruptions.
Ort, förlag, år, upplaga, sidor
MDPI, 2025. Vol. 17, nr 4, artikel-id 694
Nyckelord [en]
Pleurotus eryngii mushrooms, Ussing chamber, cytokines, deoxycholic bile acid, gut barrier, signalling pathway
Nationell ämneskategori
Immunologi
Identifikatorer
URN: urn:nbn:se:oru:diva-119481DOI: 10.3390/nu17040694ISI: 001429985700001PubMedID: 40005021Scopus ID: 2-s2.0-85218896946OAI: oai:DiVA.org:oru-119481DiVA, id: diva2:1940877
Anmärkning
Funding Agencies:
This research was co-funded by the EU and Greek national funds, through the Operational Program Competitiveness, Entrepreneurship and Innovation under the call RESEARCH-CREATE-INNOVATE (T1EDK-03404).
2025-02-272025-02-272025-04-28Bibliografiskt granskad
Ingår i avhandling